Urol. praxi, 2011; 12(6): 361-364

Erectile dysfunction - indicator of coronary artery disease and myocardial infarct

MUDr.Ta»ána ©rámková, CSc.
Klinika traumatologie LF MU, Úrazová nemocnice, Brno
Urologická klinika 1. LF UK a VFN, Praha

Erectile dysfunction (ED) and coronary artery disease (CAD) have the same morphological base – endothelial dysfunction as a first stage

of atherosclerosis. ED and CAD have the same risk factors, as a hypertension, dyslipidemia, diabetes mellitus, obesity, age, smoking and

sedentary lifestyle. The time interval among the onset ED symptoms and the occurence of CAD symptoms and cardiovascular events is

estimated at 2 – 3 years and 3 – 5 years respectively. ED is associated with increased all-cause mortality primarily due to increased cariovascular

mortality. We should also actively screen these patients and treat them effectively.

Keywords: erectile dysfunction, coronary artery disease, risk factors

Published: December 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©rámková T. Erectile dysfunction - indicator of coronary artery disease and myocardial infarct. Urol. praxi. 2011;12(6):361-364.
Download citation

References

  1. Cifková R, ©kodová Z. Dlouhodobé trendy hlavních rizikových faktorů kardiovaskulárních onemocnění v české populaci. Čas. Lék. Čs. 2004; 143: 219-226.
  2. Hromádka M, Filipovský J. Pacient po infarktu myokardu. Medicína po promoci. 2005; 6, 2: 67-69.
  3. Breza J. Erektilné poruchy. 1. vyd., Martin, Osveta, 1994: 270.
  4. Meluzín J. Erektilní dysfunkce a srdce. In.: Erektilní dysfunkce pod lupou. Ed. Pacík D. Plzeň, Adéla, 2005: 9-16.
  5. Muller JE, Mittleman MA, Maclure M, Sherwood JB, Tofler GH. Triggering myocardial infarction by sexual activity: Low absolute risk and prevention by regular physical exertion. Jama, 1996; 275: 1405-1409. Go to original source... Go to PubMed...
  6. Chaloupka V. Erektilní dysfunkce u nemocných s ischemickou chorobou srdeční. Pfizer, Praha, 1999: 7.
  7. De Busc R, Drory R, Goldstein I, et al. Management of sexual dysfunction in patients with cardiovascular disease: Recommendations of the Princeton Consensus panel. Am J Cardiol 2000; 86: 175-181. Go to original source... Go to PubMed...
  8. Greenistein A, Chen J, Miller H, Matzkin H, Villa Y, Braf Z. Does severity of ischemic coronary disease corelate with erectile function? Int J Impot Res 1997; 9: 123-126. Go to original source... Go to PubMed...
  9. Jackson G, Kloner RA, Costigan TM, Warner MR, Emmick JT. Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events. J Sex Med 2004; 1: 161-167. Go to original source... Go to PubMed...
  10. Wagner G, Mulhall J. Pathophysiology and diagnosis of male erectile dysfunction. BJU Int 2001; 88(Suppl 3): 3-10. Go to original source... Go to PubMed...
  11. Kloner R, Padma-Nathan H. Erectile dysfunction in patients with coronary artery disease. Int J Impot Res. 2005; 17(3): 209-215. Go to original source... Go to PubMed...
  12. Kirby M, Jackson G, Betteridge J, Friedli K. Is erectile function a marker of cardiovascular disease? Int J Clin Prakt 2001; 55: 614-618. Go to original source...
  13. Shin D, Pregenzer G Jr, Gardin JM. Erectile dysfunction a marker for cardiovascular disease. Cardiol. Rew., 2011; 19(1): 5-11. Go to original source... Go to PubMed...
  14. Riedner CE, Rhoden EL, Fuchs SC, Wainstein MV, Goncalves SC, et al. Erectile dysfunction and Coronary artery disease: An association of Higher Risk in Younger men. J Sex Med 2011; Mar 2. doi: 10.1111/j.1743-6109 2011. 02224.x. (Epub ahead of print). Go to original source... Go to PubMed...
  15. Jackson G, Boon N, Eardley I, Kirby M, Dean J, Hackett G, et al. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract 2010; 64(7): 848-857. Go to original source... Go to PubMed...
  16. Rogers JH, Karimi H, Kao J, Link D, Javidan J, Yamasaki DS, et al. Internal pudendal artery stenosis and erectile dysfunction: correlation with angiographic coronary artery disease. Catheter Cardiovasc Interv. 2010; 76, 6: 882-887. Go to original source... Go to PubMed...
  17. Lee JH, Ngengwe R, Jones P, Tang F, O Keefe JH. Erectile dysfunction as a coronary artery disease risk equivalent. J Nucl Cardiol 2008; 15(6): 800-803. Go to original source... Go to PubMed...
  18. Meluzín J, Vaąků A, Kincl V, Panovský R, ©rámková T. Association of coronary artery disease, erectile dysfunction and endotelial nitric oxide synthase polymorphisms. Heart Vessels, 2009; 24(3): 157-163. Go to original source... Go to PubMed...
  19. Salem S, Abdi S, Mehrsai A, Saboury B, Saraji A, et al. Erectile dysfunction severity as a risk predictor for coronary artery disease. J Sex Med 2009; 6(12): 3425-32. Go to original source... Go to PubMed...
  20. Cifková R, ©kodová Z, Lánská V, Adámková V, Novozámská E, et al. Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study. Journal of Human Hypertension 2004; 18: 571-579. Go to original source... Go to PubMed...
  21. Cifková R, ©kodová Z, Bruthans J, Adámková V, Jozífková M, et al. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 amd 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis, 2010; 211: 675-681. Go to original source... Go to PubMed...
  22. Býma S, et al. Prevence kardiovaskulárních onemocnění: Doporučený diagnostický a léčebný postup po vąeobecné lékaře. 2004, SVL ČLS JEP, Centrum doporučených postupů pro praktické lékaře.
  23. Cifková R, Býma S, Čeąka R, Horký K, Karen I. Prevence kardiovaskulárních onemocnění v dospělém věku. Společné doporučení českých odborných společností. Supplementum Cor Vasa 2005; 47, 9: 3-14.
  24. Goldstein I, et al. Oral sildenafil for the treatment of erectile dysfunction. British Yournal of Urology, 1997; 80(Suppl 2): 901.
  25. Shakir SAW, Wilton LV, Boshier A, Layton D, Heeley E. Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England. Brit Med J. 2001; 322: 651-652. Go to original source... Go to PubMed...
  26. Emmick JT, Stuewe SR, Mitchell M. Overview of the cardiovascular effects of tadalafil. Eur Heart J Suppl. 2002, 4: 32-47. Go to original source...
  27. Conti CR, Pepione CJ, Sweenwy M. Efficacy ad safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Am J Cardiol 1999; 83: 29-34. Go to original source... Go to PubMed...
  28. Sesti C, Florio V, Johnson EG, Kloner RA. The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size. Int J Impot Res. 2006; July 20: doi: 10.1038/sj.ijir.3901497. Go to original source... Go to PubMed...
  29. Weiss P, Zvěřina J. Sexuální chování obyvatelstva ČR IV. DEMA, Praha 2009.
  30. ##
  31. Riedner C, Rhoden E, Fuchs S, et al. Erectile dysfunction and coronary artery dinase: an associaton of higher risk in younger men. J Sex Med 2011; 8(5): 1445-1453. Go to original source... Go to PubMed...
  32. Chung S, Chen Y, Lin H. Increased risk of stroke among men with erectile dysfunction: a nationwide population-based study. J Sex Med 2011; 8(1): 240-246. Go to original source... Go to PubMed...
  33. Barra S, Vitagliano A, Cuomo V, et al. Vascular and metabolic effects of angiotensin II receptor blockers. Expert Opinion on Pharmacotherapy 2009; 10: 173-189. Go to original source... Go to PubMed...
  34. ##
  35. Corona G, Mannucci E, Schulman C, Petrone L, et al. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol 2006; 50: 595-604. Go to original source... Go to PubMed...
  36. Stárka L. Hormony se vztahem k sexuálním funkcím. In: Weiss P, et al. Sexuologie. Praha, Grada-Publishing 2010: 69-92.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.